Kiro Grifols, part of the Grifols group, specializes in developing automated solutions for IV compounding, integrating software and hardware under the highest quality standards. We invest heavily in R&D to deliver an innovative portfolio that enhances patient and healthcare professional safety, optimizes operational efficiency in compounding facilities, and ensures seamless interoperability and regulatory compliance.

Grifols, founded in Barcelona in 1909, is a global healthcare company committed to improving people’s health and well-being worldwide. A leader in essential plasma-derived medicines and transfusion medicine, Grifols develops, produces, and provides innovative healthcare solutions and services in more than 110 countries.
Visit Website